Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion type Assertion NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_head.
- NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion description "[Patients were divided into three groups based on their urinary albumin excretion rate (AER) and the stage of diabetic retinopathy as follows: uncomplicated group (U), normal albuminuria (AER <20 microg/min) without proliferative retinopathy and with the duration of diabetes more than 20 years (N = 32); microalbuminuria group (M), 20 < or = AER < 200 microg/min (N = 155); overt nephropathy group (O), AER > or = 200 microg/min (N = 63).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_provenance.
- NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion evidence source_evidence_literature NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_provenance.
- NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion SIO_000772 11576356 NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_provenance.
- NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion wasDerivedFrom befree-2016 NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_provenance.
- NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_assertion wasGeneratedBy ECO_0000203 NP331323.RAfPVSDWwIG9NpqSlhPMg1eZf9s4svX8SvkwGT2hvErlA130_provenance.